Clinical response and tolerability to and safety of saquinavir with low-dose ritonavir in human immunodeficiency virus type 1-infected mothers and their infants.

Zorrilla CD, Van Dyke R, Bardeguez A, Acosta EP, Smith B, Hughes MD, Huang S, Watts DH, Heckman B, Jim?nez E, McSherry G, Mofenson L. Clinical response and tolerability to and safety of saquinavir with low-dose ritonavir in human immunodeficiency virus type 1-infected mothers and their infants. Antimicrob Agents Chemother. 2007 Jun; 51(6):2208-10.

View in: PubMed

subject areas

Anti-HIV Agents
Drug Therapy, Combination
Female
HIV Infections
HIV-1
Humans
Infant
Infant, Newborn
Infectious Disease Transmission, Vertical
Microbial Sensitivity Tests
Mothers
Pregnancy
Pregnancy Complications, Infectious
Reverse Transcriptase Inhibitors
Ritonavir
RNA, Viral
Saquinavir
Treatment Outcome

authors with profiles

Carmen D. Zorrilla

RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support